Masaaki Ishikawa

2.9k total citations
139 papers, 2.4k citations indexed

About

Masaaki Ishikawa is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Masaaki Ishikawa has authored 139 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Pathology and Forensic Medicine and 16 papers in Pharmacology. Recurrent topics in Masaaki Ishikawa's work include Pharmacogenetics and Drug Metabolism (13 papers), Chemotherapy-induced organ toxicity mitigation (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Masaaki Ishikawa is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Chemotherapy-induced organ toxicity mitigation (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Masaaki Ishikawa collaborates with scholars based in Japan, Indonesia and United States. Masaaki Ishikawa's co-authors include Syu‐ichi Kanno, Ayako Tomizawa, Mayuko Ujibe, Yuu Osanai, Ken‐ichi Sasaki, Takaharu Ohtake, Takeshi Tadano, Susumu Satoh, Yoshio Takayanagi and Shin Yomogida and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and Macromolecules.

In The Last Decade

Masaaki Ishikawa

134 papers receiving 2.3k citations

Peers

Countries citing papers authored by Masaaki Ishikawa

Since Specialization

Citations

This map shows the geographic impact of Masaaki Ishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaaki Ishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaaki Ishikawa more than expected).

Fields of papers citing papers by Masaaki Ishikawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masaaki Ishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaaki Ishikawa. The network helps show where Masaaki Ishikawa may publish in the future.

Co-authorship network of co-authors of Masaaki Ishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Masaaki Ishikawa. A scholar is included among the top collaborators of Masaaki Ishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masaaki Ishikawa. Masaaki Ishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decreased initial pupil size and shortened constriction latency due to negative mood states and mental fatigue in clinical subacute pain models 2022 ·Physiology & Behavior ·(unknown), Masaaki Ishikawa	5
2	On the Stability Analysis of the Stochastic Infectious Model under Subclinical Infections 2021 ·Proceedings of the ISCIE International Symposium on Stochastic Systems Theory and its Applications ·Masaaki Ishikawa	0
3	Inverted papilloma originating from the lacrimal sac and the nasolacrimal duct with marked FDG accumulation 2021 ·SHILAP Revista de lepidopterología ·Shuichi Ito, Makoto Hosono, (unknown), (unknown), Masaaki Ishikawa, Mitsunori Kanagaki	1
4	Analysis of individual driving experience in autonomous and human-driven vehicles using a driving simulator 2015 ·(unknown), Masaaki Ishikawa, Mitsuhiro Kamezaki, Shigeki Sugano	29
5	Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells 2014 ·Oncology Letters ·Syu‐ichi Kanno, Shin Yomogida, Ayako Tomizawa, Hiroyuki Yamazaki, Kazuyo Ukai, Remy E. P. Mangindaan, Michio Namikoshi, Masaaki Ishikawa	10
6	Pifithrin-alpha has a p53-independent cytoprotective effect on docosahexaenoic acid-induced cytotoxicity in human hepatocellular carcinoma HepG2 cells 2014 ·Toxicology Letters ·Syu‐ichi Kanno, (unknown), Ayako Tomizawa, Shin Yomogida, Masaaki Ishikawa	23
7	Cytotoxic effects of caffeic acid undecyl ester are involved in the inhibition of telomerase activity in NALM-6 human B-cell leukemia cells 2013 ·Oncology Letters ·Ayako Tomizawa, Syu‐ichi Kanno, Yuu Osanai, Shin Yomogida, Masaaki Ishikawa	7
8	A polybromodiphenyl ether from an Indonesian marine sponge Lamellodysidea herbacea and its chemical derivatives inhibit protein tyrosine phosphatase 1B, an important target for diabetes treatment 2012 ·Journal of Natural Medicines ·Hiroyuki Yamazaki, Deiske A. Sumilat, Syu‐ichi Kanno, Kazuyo Ukai, Henki Rotinsulu, Defny S. Wewengkang, Masaaki Ishikawa, Remy E. P. Mangindaan, Michio Namikoshi	59
9	Association between Cancer Risk and Drug-metabolizing Enzyme Gene (CYP2A6, CYP2A13, CYP4B1, SULT1A1, GSTM1 and GSTT1) Polymorphisms in Cases of Lung Cancer in Japan 2011 ·Drug Metabolism and Pharmacokinetics ·(unknown), Tomio Arai, Haruhiko Sugimura, Takamitsu Sasaki, (unknown), (unknown), Yoichi Matsubara, (unknown), Masaaki Ishikawa, Noriyasu Hirasawa, Masahiro Hiratsuka	55
10	Management of metastasis to the thyroid gland 2011 ·Auris Nasus Larynx ·Masaaki Ishikawa, Shigeru Hirano, Takuya Tsuji, Juichi Ito	23
11	Programmed High‐Hole‐Mobility Supramolecular Polymers from Disk‐Shaped Molecules 2010 ·Advanced Functional Materials ·Wei Zhang, Kenji Ochi, Michiya Fujiki, Masanobu Naito, Masaaki Ishikawa, Keiichi Kaneto, Wataru Takashima, Akinori Saeki, Shu Seki	15
12	Lack of a rewarding effect and a locomotor-enhancing effect of the selective μ-opioid receptor agonist amidino-TAPA 2010 ·Psychopharmacology ·Hirokazu Mizoguchi, Chizuko Watanabe, (unknown), (unknown), Yuta Aoki, (unknown), Akihiko Yonezawa, Syu‐ichi Kanno, Masaaki Ishikawa, Tsukasa Sakurada, Shinobu Sakurada	11
13	Analysis of 3 Cases with Metastatic Thyroid Carcinoma 2009 ·Practica Oto-Rhino-Laryngologica ·Masaaki Ishikawa, (unknown), Shigeru Hirano, (unknown), Yoshihiro Tamura, Ryo Asato, Juichi Ito	1
14	Naringenin-induced apoptosis via activation of NF-κB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells 2006 ·Toxicology Letters ·Syu‐ichi Kanno, Ayako Tomizawa, Takaharu Ohtake, (unknown), Mayuko Ujibe, Masaaki Ishikawa	70
15	HLA-B Polymorphism in Japanese HIV-1–Infected Long-Term Surviving Hemophiliacs 2005 ·Viral Immunology ·(unknown), Hiroshi Terunuma, Megumi Takahashi, Hideji Hanabusa, Takuma Miura, Shu‐ichi Ikeda, Michio Sakai, Teruhisa Fujii, Yoshihiro Takahashi, Shinichi Oka, Juzo Matsuda, Masaaki Ishikawa, Masashi Taki, (unknown), J Mimaya, Masahiko Ito, Akinori Kimura, Michio Yasunami	12
16	Reversal of Acquired Resistance to Doxorubicin in K562 Human Leukemia Cells by Astemizole. 2000 ·Biological and Pharmaceutical Bulletin ·Masaaki Ishikawa, Ryousuke Fujita, Motoaki Takayanagi, (unknown), Ken‐ichi Sasaki	16
17	Ala601‐Thr type dysplasminogenaemia genetically diagnosed in patients with retinochoroidal vascular disorders 1997 ·British Journal of Haematology ·Masatoshi Murata, Asako Ooe, Tomonori Izumi, (unknown), Shigeki Takahashi, Masaaki Ishikawa, Kazuo Mori, (unknown)	3
18	Inhibition of Hepatic Drug Biotransformation by Carrageenan-Induced Inflammation in the Rat: Effect of Sex Hormone Alterations. 1992 ·Journal of Pharmacobio-Dynamics ·Masaaki Ishikawa, Kenroh Sasaki, (unknown), (unknown), Kenichi Sasaki	1
19	Drug Interaction Effects on Antitumour Drugs (VIII): Prevention of Ifosfamide‐Induced Urotoxicity by Disulfiram and its Effect on Antitumour Activity and Acute Toxicity of Alkylating Agents in Mice 1991 ·Pharmacology & Toxicology ·Masaaki Ishikawa, Yoshio Takayanagi, Ken‐ichi Sasaki	3
20	The inter-action of analgesics and autonomic drugs upon the blood sugar of rabbits 1956 ·Folia Pharmacologica Japonica ·Masaaki Ishikawa	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact